Combating fungal diseases

August 30, 2011
Combating fungal diseases
Cells are dying when zinc cannot bind to Dicer and the protein therefore stays in the cytoplasm

(Medical Xpress) -- Scientists at the Friedrich Miescher Institute for Biomedical Research have discovered a potential new approach for inhibiting the growth of pathogenic fungi. Their findings on the mechanism in question have been published online in the EMBO Journal. Ultimately, immunocompromised patients with fungal infections, in particular, could benefit from this work.

As temperatures soar and more and more people cool off at outdoor pools, the incidence of so called swimmer's ear - an infection of the - also rises. One of the agents causing this condition is a fungus of the Aspergillus genus. But while swimmer's ear (otomycosis) can be readily treated, other mycoses may be fatal - especially in patients with an impaired immune system. In such cases, it is obviously vital to understand how can be inhibited or even arrested.

A group of scientists led by Marc Buhler of the FMI, in collaboration with structural biologists at the ETH Zurich, have now identified a mechanism which, if blocked, should lead to marked inhibition of the growth of .

The research project is focusing on a protein known as Dicer. This protein plays a key role in the generation of small RNAs called siRNAs (short interfering RNAs), which are involved in selective suppression of . As reported in the online edition of the , the epigeneticists and structural biologists determined the three-dimensional structure of the C-terminal domain of the Dicer protein. In the process, they identified a novel zinc binding motif within an extended fold. When the binding of zinc to Dicer was prevented experimentally, it was no longer possible for the protein to become active at the appropriate location in the cell. Rather than being transported to the nucleus, it remained in the cytoplasm. At the same time, the pattern of gene activation was altered and the cells died off.

Interestingly, this motif is also present in a number of fungi which are pathogenic to humans. Commenting on the team's findings, Bühler says: "It's surprising and very encouraging to see how similar this part of the Dicer protein is in the various fungi investigated. So we hope to be able to inhibit growth by blocking zinc binding in those fungi, too. Another reason why this approach appears to be so promising is that this zinc-binding motif is not found in human Dicer. That means that, in a clinical situation, the fungal Dicer could be selectively inhibited without impairing the important functions of Dicer in human cells." This potential therapeutic approach could benefit in particular patients whose immune system is weakened as a result of organ transplantation or cancer, or people with Aids.

Explore further: Protein unmasks pathogenic fungi to activate immune response

More information: Barraud P, Emmerth S, Shimada Y, Hotz HR, Allain FH, Bühler M (2011) An extended dsRBD with a novel zinc-binding motif mediates nuclear retention of fission yeast Dicer, EMBO J. doi:10.1038/emboj.2011.300.

Related Stories

Protein unmasks pathogenic fungi to activate immune response

August 8, 2011
The first step in defending against a hostile attack is identifying the enemy. It's how a healthy immune system mounts a response to invading pathogens. In the case of certain fungi, however, the attacking cells may be so ...

Recommended for you

Novel approach to track HIV infection

August 18, 2017
Northwestern Medicine scientists have developed a novel method of tracking HIV infection, allowing the behavior of individual virions—infectious particles—to be connected to infectivity.

Faulty gene linked to obesity in adults

August 18, 2017
Groundbreaking new research linking obesity and metabolic dysfunction to a problem in the energy generators in cells has been published by researchers from the Harry Perkins Institute of Medical Research and The University ...

Two lung diseases killed 3.6 million in 2015: study

August 17, 2017
The two most common chronic lung diseases claimed 3.6 million lives worldwide in 2015, according to a tally published Thursday in The Lancet Respiratory Medicine.

New test differentiates between Lyme disease, similar illness

August 16, 2017
Lyme disease is the most commonly reported vector-borne illness in the United States. But it can be confused with similar conditions, including Southern Tick-Associated Rash Illness. A team of researchers led by Colorado ...

Addressing superbug resistance with phage therapy

August 16, 2017
International research involving a Monash biologist shows that bacteriophage therapy – a process whereby bacterial viruses attack and destroy specific strains of bacteria - can be used successfully to treat systemic, multidrug ...

Can previous exposure to west Nile alter the course of Zika?

August 15, 2017
West Nile virus is no stranger to the U.S.-Mexico border; thousands of people in the region have contracted the mosquito-borne virus in the past. But could this previous exposure affect how intensely Zika sickens someone ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.